Most Recent

image: Surgical Art

Surgical Art

By | June 1, 2012

InĀ 1929 and 1930, Johns Hopkins Medical School surgeon Warfield Firor carried out a series of experiments to determine how long blood could flow between animals with joined circulatory systems. Without using any anti-coagulants, Firor attempted to es

0 Comments

image: Delivering New Genes

Delivering New Genes

By | June 1, 2012

Gene therapies typically involve the introduction of genetic material into target cells to replace or supplement an existing, usually dysfunctional, gene. 

0 Comments

image: Digging the Underground Life

Digging the Underground Life

By | June 1, 2012

A rare peek inside the subterranean home of the naked mole-rat

0 Comments

image: Messing with HIV

Messing with HIV

By | June 1, 2012

Sangamo Biosciences is putting a different spin on gene therapy. 

0 Comments

image: Tracing the Ephemeral

Tracing the Ephemeral

By | June 1, 2012

A novel reporter system can track the ever-changing levels of the plant signal auxin with great precision.

0 Comments

image: From Bones to Brains

From Bones to Brains

By | June 1, 2012

With the help of a mother, one researcher uncovered a common link between autism and a devastating bone disease.

2 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

image: Targeting DNA

Targeting DNA

By | June 1, 2012

After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.

13 Comments

The Blood Exchange, Circa 1930

By | June 1, 2012

Early 20th century cross circulation experiments on dogs paved the way for milestones in human cardiac surgery.

1 Comment

image: Underground Supermodels

Underground Supermodels

By | June 1, 2012

What can a twentysomething naked mole-rat tell us about fighting pain, cancer, and aging?

12 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham